Evidence map›Paper›PMID 29616896›Full record

ArticleMicrobial genomics2018

Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA.

Li Hao, Matthew T G Holden, Xin Wang, Lubomira Andrew, Sabine Wellnitz, Fang Hu, Melissa Whaley, Scott Sammons, Kristen Knipe, Mike Frace and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. The First Case of Serogroup YChina CDC weekly · 2024
    Article
  3. Review
  4. Current Methods for Recombination Detection in Bacteria.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Li Hao1​Vaccine Research & Development, Pfizer Inc, 401 N. Middletown Rd, Pearl River, NY 10965, USA.
Matthew T G Holden2​School of Medicine, University of St. Andrews, St. Andrews, UK.
Xin Wang3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Lubomira Andrew1​Vaccine Research & Development, Pfizer Inc, 401 N. Middletown Rd, Pearl River, NY 10965, USA.
Sabine Wellnitz1​Vaccine Research & Development, Pfizer Inc, 401 N. Middletown Rd, Pearl River, NY 10965, USA.
Fang Hu3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Melissa Whaley3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Scott Sammons3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Kristen Knipe3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Mike Frace3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Lucy A McNamara3​Division of Bacterial Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
Paul Liberator1​Vaccine Research & Development, Pfizer Inc, 401 N. Middletown Rd, Pearl River, NY 10965, USA.
Annaliesa S Anderson1​Vaccine Research & Development, Pfizer Inc, 401 N. Middletown Rd, Pearl River, NY 10965, USA.
Centers for Disease Control and Prevention · USPfizer (United States) · USUniversity of St Andrews · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis serogroup B (MnB) was responsible for two independent meningococcal disease outbreaks at universities in the USA during 2013. The first at University A in New Jersey included nine confirmed cases reported between March 2013 and March 2014. The second outbreak occurred at University B in California, with four confirmed cases during November 2013. The public health response to these outbreaks included the approval and deployment of a serogroup B meningococcal vaccine that was not yet licensed in the USA. This study investigated the use of whole-genome sequencing(WGS) to examine the genetic profile of the disease-causing outbreak isolates at each university. Comparative WGS revealed differences in evolutionary patterns between the two disease outbreaks. The University A outbreak isolates were very closely related, with differences primarily attributed to single nucleotide polymorphisms/insertion-deletion (SNP/indel) events. In contrast, the University B outbreak isolates segregated into two phylogenetic clades, differing in large part due to recombination events covering extensive regions (>30 kb) of the genome including virulence factors. This high-resolution comparison of two meningococcal disease outbreaks further demonstrates the genetic complexity of meningococcal bacteria as related to evolution and disease virulence.

Indexed as

Disease OutbreaksEvolution, MolecularMeningitis, MeningococcalPhylogenyPolymorphism, Single NucleotideAdolescentAdultCaliforniaFemaleHumansMaleNeisseria meningitidis, Serogroup BNew JerseyUniversitiesdisease outbreakmulti-locus sequence typing (MLST)serogroup B Neisseria meningitidissingle nucleotide polymorphism (SNP)vaccinewhole genome sequence (WGS)

Identifiers

PMID29616896
PMCPMC5989579
OpenAlexW2796250777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.